Home  »  Finance   »  Do Guardant Health Inc. (GH) beta value of 0.62 si...

Do Guardant Health Inc. (GH) beta value of 0.62 signposts another twist?

Guardant Health Inc. (GH) is priced at $50.07 after the most recent trading session. At the very opening of the session, the stock price was $47.07 and reached a high price of $50.35, prior to closing the session it reached the value of $47.03. The stock touched a low price of $47.048.Recently in News on November 3, 2022, Guardant Health Reports Third Quarter 2022 Financial Results. Q3 clinical and biopharma volumes up 42% and 40% year over year. You can read further details here

Guardant Health Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $102.85 on 01/04/22, with the lowest value was $27.65 for the same time period, recorded on 05/12/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Guardant Health Inc. (GH) full year performance was -46.10%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Guardant Health Inc. shares are logging -55.09% during the 52-week period from high price, and 81.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $27.65 and $111.48.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 527043 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Guardant Health Inc. (GH) recorded performance in the market was -49.94%, having the revenues showcasing -7.05% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 5.15B, as it employees total of 1373 workers.

Market experts do have their say about Guardant Health Inc. (GH)

During the last month, 0 analysts gave the Guardant Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 50.65, with a change in the price was noted +2.63. In a similar fashion, Guardant Health Inc. posted a movement of +5.54% for the period of last 100 days, recording 1,010,233 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GH is recording 6.82 at the time of this writing. In addition, long term Debt to Equity ratio is set at 6.82.

Technical breakdown of Guardant Health Inc. (GH)

Raw Stochastic average of Guardant Health Inc. in the period of last 50 days is set at 43.43%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 68.87%. In the last 20 days, the company’s Stochastic %K was 57.25% and its Stochastic %D was recorded 55.34%.

Bearing in mind the latest performance of Guardant Health Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -49.94%. Additionally, trading for the stock in the period of the last six months notably improved by 37.22%, alongside a downfall of -46.10% for the period of the last 12 months. The shares increased approximately by 1.23% in the 7-day charts and went down by 7.19% in the period of the last 30 days. Common stock shares were lifted by -7.05% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts